RSA Singapore is moving on up
RSA announces the new location of its Singapore office.
The life sciences industry is picking up in Asia
Speaking to BioSpectrumAsia, Laura Thomas, Managing Director, RSA Singapore said, "The life sciences industry in Asia is picking up. Looking at the growth in the industry we do see an opportunity of growth for our business. The companies are expanding their operations and investing in Asian region with Singapore being the hub."
RSA France has moved to a new address at 77, avenue des Champs Elysées, 75008 Paris
RSA Group CEO Nick Stephens said "We are thrilled to be relocating our French office to one of the most beautiful and prestigious addresses in Europe. I am delighted to say that after 2 years of operation our French business has grown exponentially, confirming the value we deliver to our clients and the quality of our work."
"As specialists in Life sciences, we support the development of our clients businesses, from biotechnology companies through to large Pharmaceutical companies. Not only do we help them to find, attract and retain the best people but we can introduce new competencies, new skills and new functions, enabling real change management" added Priscilla Motte, Managing Director of RSA France.
RSA-sponsored SCRIP Award Presented to Novartis
Management Team of the Year announced at the pharmaceutical industry's SCRIP Awards ceremony 2009
Bouncing Back - reshaping pre-clinical R&D to prepare for the
upturn
RSA Interims Scotland host a networking event
"Learning the art of personal branding"
Nick Stephens recently chaired a session at the BIA Annual Bioscience Forum in London titled "Focus on Talent Management in the New World".
Founders' Syndrome: A Problem for Start-ups.
RSA launches first register of Non-Executive Directors exclusively for life sciences
RSA have launched the UK's first register of Non-Executive Directors dedicated wholly to the life sciences.
Finding the right biotech CEO
As Singapore's biomedical sciences sector has been slated to become the nation's next engine of growth, more biotech companies will be appearing on the scene.
RSA are now members of the Swiss Interim Management Association
The Great Call of China
Pharma companies are flocking to China in the manner of some latter-day gold rush. It isn't hard to
see why...
How to stay ahead of the competition in a challenging pharmaceutical job market
Jobs go down the tube at big drugs firms
As the cost of producing and licensing new medicines soars, the sector is contracting.
Chris Molloy joins RSA board
Chris Molloy, vice-president at IDBS - leading provider of advanced data management to the research industry - has joined RSA as a non-executive director.
Hard times. Real opportunities.
While no one denies the economic challenges we face, the pharma and life science industries are poised for steady growth. RSA Americas' Shawn O'Connor reviews prospects for employers and employees - and likes what he sees.
RSA Interims expand in Scotland to meet biotechnology demand
RSA is expanding its interim management practice in Scotland to meet the country's shortfall in staff for its growing biotechnology and pharmaceutical sectors.
RSA's successful global search for elusive CEO
RSA has just won praise from the chairman of a Singapore-based client, for rising to the challenge, against strong competition.
Andy Smith joined RSA in 2004 and is now Principal Consultant RSA Executive Search - Medical, Clinical & Regulatory Affairs.